focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDerwent London Regulatory News (DLN)

Share Price Information for Derwent London (DLN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,246.00
Bid: 2,250.00
Ask: 2,258.00
Change: -46.00 (-2.01%)
Spread: 8.00 (0.356%)
Open: 2,238.00
High: 2,288.00
Low: 2,238.00
Prev. Close: 2,292.00
DLN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

26 Jan 2021 07:00

RNS Number : 8323M
Derwent London PLC
26 January 2021
 

Derwent London plc ("Derwent London" / "the Company")

BOARD UPDATE

Appointment of Chairman Designate

 

 

Derwent London plc is pleased to announce the appointment of Mark Breuer to the Board as an independent Non-Executive Director with effect from 1 February 2021. Subject to shareholder approval, Mark will succeed John Burns as Non-Executive Chairman following conclusion of the 2021 Annual General Meeting when John will retire.

 

Mark is highly experienced in business and corporate finance having operated at senior levels in the UK and abroad. He worked in investment banking for thirty years and, in 2017, retired from a 20-year career at JP Morgan in London, where he held the position of Vice Chairman Global M&A and was a member of the Global Strategic Advisory Council During his career, he served in numerous client facing and management roles advising on strategy, finance and corporate development to both domestic and international clients. Mark is a Fellow of the Institute of Chartered Accountants of England and Wales, having qualified in 1987, and has a B.A. from Vassar College in the US.

 

Mark currently serves on the Board of DCC plc, as the Senior Independent Director, and as a Non-Executive Director of Arix Bioscience plc. There are no further details required to be disclosed under LR 9.6.13 of the FCA Handbook.

 

John Burns, Chairman commented: "I am delighted that Mark will join the Board of Derwent London. I am sure he will prove to be a valued and respected addition and a highly effective Chair. I hand over with every confidence in Mark's future success and that of the Company."

 

Paul Williams, Chief Executive commented: "We welcome Mark to the Board and look forward to working alongside him. Mark brings a wealth of experience across many fronts and I am confident he will make a valuable contribution to the Company. I should also like to take this opportunity to thank John, our founder CEO and Chairman in the last two years, for his exceptional contribution to Derwent London, its shareholders, employees and other stakeholders, as well as to me personally. We wish him a happy retirement."

 

Mark Breuer, Chairman Designate commented: "I am honoured to have been selected as Chairman Designate of Derwent London, a company I have long admired. I look forward to working with Paul and the Board at an important time for the Company and all its stakeholders. The business has proven highly resilient through the pandemic and I am excited about its future."

 

 

Enquiries:

D A Lawler

Company Secretary

26 January 2021

 

020 7659 3000

www.derwentlondon.com

 

Brunswick

Simon Sporborg / Nina Coad

020 7404 5959

 

 

 

Notes to editors

 

Derwent London plc

 

Derwent London plc owns 83 buildings in a commercial real estate portfolio predominantly in central London valued at £5.4 billion (including joint ventures) as at 30 June 2020, making it the largest London-focused real estate investment trust (REIT).

Our experienced team has a long track record of creating value throughout the property cycle by regenerating our buildings via development or refurbishment, effective asset management and capital recycling.

We typically acquire central London properties off-market with low capital values and modest rents in improving locations, most of which are either in the West End or the Tech Belt. We capitalise on the unique qualities of each of our properties - taking a fresh approach to the regeneration of every building with a focus on anticipating tenant requirements and an emphasis on design.

Reflecting and supporting our long-term success, the business has a strong balance sheet with modest leverage, a robust income stream and flexible financing.

As part of our commitment to lead the industry in mitigating climate change, Derwent London has committed to becoming a net zero carbon business by 2030, publishing its pathway to achieving this goal in July 2020. In 2019 the Group became the first UK REIT to sign a Revolving Credit Facility with a "green' tranche. At the same time, we also launched our Green Finance Framework and signed the Better Buildings Partnership's climate change commitment. The Group is a member of the 'RE100' which recognises Derwent London as an influential company, committed to 100% renewable power by purchasing renewable energy, a key step in becoming a net zero carbon business. Derwent London is one of only a few property companies worldwide to have science-based carbon targets validated by the Science Based Targets initiative (SBTi).

Landmark schemes in our 5.6 million sq ft portfolio include 80 Charlotte Street W1, Brunel Building W2, White Collar Factory EC1, Angel Building EC1, 1-2 Stephen Street W1, Horseferry House SW1 and Tea Building E1.

In 2020 the Group has won several awards for Brunel Building with the most prominent being the BCO Best Commercial Workplace award. In 2019 the Group won EG Offices Company of the Year, the CoStar West End Deal of the Year for Brunel Building, Westminster Business Council's Best Achievement in Sustainability award and topped the real estate sector and was placed ninth overall in the Management Today 2019 awards for 'Britain's Most Admired Companies'. In 2013 the Company launched a voluntary Community Fund and has to date supported over 100 community projects in the West End and the Tech Belt.

 

The Company is a public limited company, which is listed on the London Stock Exchange and incorporated and domiciled in the UK. The address of its registered office is 25 Savile Row, London, W1S 2ER.

 

For further information see www.derwentlondon.com or follow us on Twitter at @derwentlondon

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOABCGDBBBDDGBU
Date   Source Headline
28th Feb 20224:45 pmRNSTotal Voting Rights
24th Feb 20227:00 amRNSResults for the Year Ended 31 December 2021
31st Jan 20224:45 pmRNSTotal Voting Rights
26th Jan 20227:00 amRNSSALE OF NEW RIVER YARD EC1
31st Dec 20211:30 pmRNSTotal Voting Rights
14th Dec 202111:16 amRNSTerms agreed to acquire City Road Island EC1
10th Dec 20219:23 amRNSHolding(s) in Company
6th Dec 20212:30 pmRNSHolding(s) in Company
1st Dec 20213:00 pmRNSHolding(s) in Company
1st Dec 20212:20 pmRNSHolding(s) in Company
30th Nov 20214:45 pmRNSTotal Voting Rights
10th Nov 20215:05 pmRNS£350M 10-YEAR 1.875% GREEN BOND
4th Nov 20217:01 amRNSAcquisition of 230 Blackfriars Road SE1
4th Nov 20217:00 amRNSThird Quarter Business Update
29th Oct 20214:45 pmRNSTotal Voting Rights
25th Oct 202111:30 amRNSHolding(s) in Company
14th Oct 20214:00 pmRNSHolding(s) in Company
14th Oct 20219:00 amRNSDirectorate Change
12th Oct 20217:00 amRNSDerwent London September 2021 Rent Collection
30th Sep 20214:45 pmRNSTotal Voting Rights
28th Sep 20218:00 amRNSInvestor and Analyst Presentation 2021
21st Sep 202110:00 amRNSAdditional Listing
20th Sep 20214:45 pmRNSBlock listing Interim Review
31st Aug 20214:45 pmRNSTotal Voting Rights
10th Aug 20217:01 amRNSACQUISITION OF TWO PROPERTIES & NEW JV
10th Aug 20217:00 amRNSINTERIM RESULTS
6th Aug 20212:45 pmRNSDirectorate Change
2nd Aug 20217:00 amRNSAcquisition of Bush House, SW Wing, WC2, Headlease
30th Jul 20214:45 pmRNSTotal Voting Rights
29th Jul 20217:00 amRNSFORA LETS 6-8 GREENCOAT PLACE
19th Jul 20217:00 amRNSDisposal of Angel Square EC1 to Tishman Speyer
9th Jul 20217:00 amRNSJune 2021 Rent Collection
30th Jun 20214:45 pmRNSTotal Voting Rights
22nd Jun 20213:30 pmRNSHolding(s) in Company
1st Jun 202110:00 amRNSTotal Voting Rights
18th May 20211:00 pmRNSDirector/PDMR Shareholding
14th May 202112:10 pmRNSResults of 2021 Annual General Meeting
10th May 202110:30 amRNSBondholders Meetings
6th May 20217:00 amRNSQ1 2021 Business Update
30th Apr 20214:45 pmRNSTotal Voting Rights
15th Apr 20214:45 pmRNSDirector/PDMR Shareholding
14th Apr 20213:00 pmRNSAnnual Report & Accounts 2020 and Notice of AGM
13th Apr 20217:00 amRNSMarch 2021 Rent Collection
31st Mar 20214:45 pmRNSTotal Voting Rights
31st Mar 20214:00 pmRNSDirector Declaration
30th Mar 202111:30 amRNSDirector Declaration
23rd Mar 20214:45 pmRNSDirector/PDMR Shareholding
22nd Mar 202112:30 pmRNSBlock listing Interim Review
17th Mar 20211:45 pmRNSHolding(s) in Company
16th Mar 20214:47 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.